March 2022
209 articles-
Mar 30 · 11:23Biotechnology Daily
Zosano's headaches continue: Biotech lays off 31% after FDA rejects migraine drug resubmission
-
Mar 30 · 11:22Biotechnology Daily
Medtronic shuffles surgical robotics, diabetes and cardiac business leaders
-
Mar 30 · 11:06Biotechnology Daily
NIH squashes Synairgen’s COVID therapy from ACTIV-2 trial after omicron shakes up study
-
Mar 30 · 11:05Biotechnology Daily
Sensorion spins hearing loss flop into exploratory win in attempt to revive lead program
-
Mar 30 · 11:03Bio Business News
Athenex cuts jobs, narrows focus to cell therapies in continued fallout from 2021 FDA rejection
-
Mar 30 · 11:01Bio Business News
Invitae launches personalized cancer blood tests to spot tumor relapses
-
Mar 30 · 11:00Bio Business News
After megaround, Apexigen inks modest SPAC deal to advance melanoma prospect toward approval
-
Mar 30 · 10:58Bio Business News
Glooko picks up Diabnext to launch digital diabetes management platform in France
-
Mar 29 · 10:20Biotechnology Daily
Silence stops enrollment in blood cancer arm of RNAi trial over 'recruitment challenges'
-
Mar 29 · 10:18Biotechnology Daily
Medtronic's colonoscopy AI cuts number of missed polyps in half, study finds
-
Mar 29 · 10:16Biotechnology Daily
Verily adds AI to Lumea’s digital pathology platform for prostate cancer
-
Mar 29 · 10:14Biotechnology Daily
Illumina launches cancer profiling diagnostic in Europe
-
Mar 29 · 10:12Bio Business News
Thermo Fisher says buoyant demand prompted clinical lab expansion
-
Mar 29 · 10:10Bio Business News
Emmes notches 4th acquisition in rare disease focused CRO, with more buys on the horizon
-
Mar 29 · 10:08Bio Business News
AstraZeneca throws open doors to new ideas in global postdoc challenge
-
Mar 29 · 10:07Bio Business News
AI-driven Deepcell raises $73M to further single-cell imaging tech
-
Mar 29 · 09:26Market Watch
Asian markets rise as oil prices sink further
-
Mar 29 · 03:47Market Watch
GameStop stock bulls toward longest win streak in 12 years
-
Mar 25 · 04:02Biotechnology Daily
Biogen jettisons AMD drug, providing Catalyst for ex-partner's hunt for strategic alternatives
-
Mar 25 · 03:59Biotechnology Daily
With clinical holds lifted, Aprea embarks on 'show me' year for key cancer candidate
-
Mar 25 · 03:53Biotechnology Daily
Ovid finds new focus in epilepsy but trims staff to extend cash runway
-
Mar 25 · 03:49Biotechnology Daily
FDA's gene editing guidance is 'par for the course' but still important, analysts say
-
Mar 25 · 03:44Bio Business News
Sanofi steps off the sidelines to ink 3 ADC deal with Seagen, reigniting long-held interest in the modality
-
Mar 25 · 03:35Bio Business News
J&J's DePuy Synthes found guilty of infringing orthopedic device patent in $20M verdict